Summary An in vivo study of tissue distribution kinetics and photodynamic therapy (PDT) using 5-aminolaevulinic acid (ALA), chlorin e6 (Chl) and Photofrin (PII) was performed to evaluate the selectivity of porphyrin accumulation and tissue damage effects in a tumour model compared with normal tissue. C26 colon carcinoma of mice transplanted to the foot was used as a model for selectivity assessment. Fluorescence measurements of porphyrin accumulation in the foot bearing the tumour and in the normal foot were performed by the laser-induced fluorescence (LIF) system. A new high-intensity pulsed light delivery system (HIPLS) was used for simultaneous irradiation of both feet by light in the range of 600-800 nm, with light doses from 120 to 300 J cm-2 (0.6 J cm-2 per pulse, 1 Hz). Photoirradiation was carried out 1 h after injection of ALA, 3 h after injection of Chl and 24 h after injection of PII. A ratio of porphyrin accumulation in tumour vs normal tissue was used as an index of accumulation selectivity for each agent. PDT selectivity was determined from the regression analysis of normal and tumour tissue responses to PDT as a function of the applied light dose. A normal tissue damage index was defined at various values (50, 80 and 100%) of antitumour effect. The results of the LIF measurements revealed different patterns of fluorescence intensity in tumour and normal tissues for ALA-induced protoporphyrin IX (ALA-PpIX), Chl and PIT. The results of PDT demonstrated the differences in both anti-tumour efficiency and normal tissue damage for the agents used. The selectivity of porphyrin accumulation in the tumour at the time of photoirradiation, as obtained by the LIF measurements, was in the order ALA-PpIX > Chl > PII. PDT selectivity at an equal value of anti-tumour effect was in the order Chl > ALA-PpIX > Pll. Histological examination revealed certain differences in structural changes of normal skin after PDT with the agents tested. The results of PDT selectivity assessment with respect to differences in mechanisms of action for ALA, Chl and PII are discussed.
Photodynamic therapy (PDT) with Photofrin is currently used for the treatment of cancer in many clinical studies. In order to improve the effectiveness of this anti-cancer modality a number of new photosensitisers have been developed and suggested as promising agents for PDT (Gomer, 1991) . Some of the most desirable properties for new agents are (1) selective retention by tumours; (2) maximal anti-tumour efficiency with minimal damage to the surrounding normal tissue; (3) rapid body clearance to reduce toxicity. Because comparative studies of different photosensitisers' selectivity are rare, such studies could improve our knowledge and understanding concerning mechanisms involved in tissue response to PDT.
Three different agents, chlorin e6 (Chl), 5-aminolaevulinic acid (ALA) and the standard photosensitiser Photofrin (PII) were investigated in this study.
Chlorins are known as photosensitisers with strong absorption in the red spectrum (around 660 nm), and good photophysical properties (Spikes, 1990; 1993) . Chl has been shown to be an effective in vivo photosensitiser, with low toxicity and preferential tumour localisation (Kostenich et al., 1991 (Kostenich et al., , 1993 (Kostenich et al., , 1994 . The enhanced PDT efficacy and reduced duration of cutaneous photosensitivity for mono-L-aspartyl chlorin e6 (NPe6), a derivative of Chl, as compared with Pll has been demonstrated (Gomer and Ferrario, 1990) . Stage I clinical trials with some chlorins are currently in progress at several medical centres.
ALA is a precursor of endogenous porphyrins, and it has the ability to stimulate the overproduction of endogenous protophyrin IX (PpIX) in tumour cells (Malik and Lugaci, 1987; Kennedy et al., 1990) . PDT with topical ALA application has been used extensively for the selective eradication of human malignant skin tumours Svanberg et al., 1994; Cairnduff et al., 1994; Orenstein et al., 1996) . Unfortunately, there are relatively few preclinical studies on the ALA potential for PDT after systemic administration (Peng et al., 1992; Bedwell et al., 1992; Regula et al., 1994) . The advantages of ALA-PDT are (1) low systemic toxicity ; (2) endogenous PpIX synthesis and compartmental targeting (mitochondria) for PDT damage (Malik and Lugaci, 1987; Peng et al., 1992 ; (3) rapid clearance of ALA-induced porphyrins from the body (Bedwell et al., 1992) .
The differences in biological mechanisms of action (exogenous vs endogenous) and in photophysical properties of ALA-PpIX, Chl and PII make the comparison of these agents interesting. A reliable test model with a tumour transplanted into the footpad (Evensen and Moan, 1987; Zhuravkin et al., 1992) was chosen in the present investigation. To study the accumulation selectivity of the agents, laser-induced fluorescence (LIF) measurements were performed. The LIF method has been applied in vivo to analyse the pharmacokinetics of various photosensitisers Frisoli et al., 1993; Malik et al., 1995) . This method is non-invasive and rapid, and therefore optimal for such experiments. Figure 1 . Autofluorescence was not detectable in either the control or the experimental animals before injection of the agents. The fluorescence spectrum observed after ALA administration had two PpIX peaks, the dominant peak at 635 and the minor peak at 704 nm. The in vivo fluorescence spectrum of Chl had one intensive peak at 667 nm, and PII spectra had two peaks, at 630 and 692 nm.
The kinetics of ALA-induced PpIX, Chl and PII accumulation in normal and tumour tissues are shown in Figure 2A -C. A maximal level of fluorescence intensity in the foot with the tumour was found 1 h after ALA injection, while in the normal foot, fluorescence reached a maximum value at 3 h ( Figure 2A ). After reaching maximal levels in both the normal tissue and the tumour, the fluorescence decreased gradually at a similar rate for both feet and was minimal 24 h after ALA administration. A maximal tumour-normal tissue ratio of the fluorescence signal (2.3) was revealed 1 h after ALA injection (Table I) .
A different pattern of accumulation was observed after injection of Chl (Figure 2b) . A maximum Chl fluorescence was detected in both feet 1.5 h after the injection and then it decreased rapidly. The fluorescence intensity was higher in the tumour than in the normal tissue over 24 h, with the ratio about 0.7.
Maximum fluorescence intensity of PII in the tissues was observed 6 h after the injection (Figure 2c ). Fluorescence signals from both feet were equal at this time. Slower elimination of the agent from the tumour than from the normal tissue resulted in an increase in the fluorescence intensity ratio between both feet from 0.4 to 0.7 at 24-72 h after injection. (Figure 3) . The occurrence of the inflammatory infiltrate of granulocytes in the tumour tissue was more pronounced for ALA-PDT (Figure 3b, b' ). Extensive extravasation of erythrocytes with minimal infiltration of granulocytes was seen after PDT with both Chl or PII (Figure 3c-d) . It was also found that PII-PDT caused focal damage to vascular walls (vacuolar changes) as well as focal thrombus formation (Figure 3d') . Figure 4a -c demonstrates the characteristic morphological features observed in the skin of the normal foot after Morphological study of tissue damage effects after PDT For PDT, both the normal foot and the foot with the transplanted C26 colon carcinoma were irradiated by pulsed light from a HIPLS 1 h after injection of ALA, 3 h after injection of Chl and 24 h after injection of PII. A typical sequence of effects observed on both feet after PDT with all three agents was oedema followed by necrosis and crust formation. The expression of damage after the treatment with each agent was directly dependent on the light dose applied. Oedema was significantly more pronounced in the normal foot than in the foot with the tumour. Tissue necrosis, ulceration and crust formation was typically observed 2-5 days after the treatment.
Histological examination of tissue samples from the foot with the tumour and the normal foot, performed 24 h after PDT with ALA-induced PpIX, Chl and PII, revealed (Figure 4a ). In contrast, undamaged epidermis was noted after Chl-PDT ( Figure  4b ). Moderate damage to epidermis, severe dermal oedema and blood stasis was pointed for PII-PDT (Figure 4c ).
Anti-tumour effect assessment after PDT Figure 5 shows the tumour growth curves after PDT with ALA-induced PpIX (a), Chl (b) Normal tissue damage assessment after PDT Oedema of the normal foot appeared immediately after photodynamic treatment, reached the maximal level 24 h after the photoirradiation procedure and decreased slowly to pretreatment level during the next 5-7 days for ALA-PDT, 4-5 days for Chl-PDT and 4-13 days for PII-PDT ( Figure  7a-c) . The amount of oedema, and the damage index (DI) for the normal foot were directly dependent on the light dose applied (Figure 8) . The results indicate different patterns of dose-effect curves of DI for the agents. A minimal effect on normal tissues was noted for Chl. PDT with PII caused about the same normal tissue damage as Chl at low light doses (120-180 J cm-2); however, significant oedema of the normal foot was observed when higher light doses were applied. The normal foot response to ALA-PDT at low light doses was higher than with Chl or PII. With increase of the light dose, however, the response of normal tissues increased more slowly after ALA-PDT than after PII-PDT. As a result, the values of normal foot DI at light doses of 240 and 300 J cm-2 were 2 and 3.5 times lower with ALA than with PII.
Based on the data of tumour and normal tissue damage after PDT, the extent of normal tissue response at different values of TGIR were calculated for each agent (Table I ). The results show that the highest PDT selectivity was observed for Chl. The normal foot damage index after ALA-PDT was higher than after PII-PDT at TGIR 50%; however, at TGIR 80% or TGIR 100%, the value of this parameter was 1.3 and 2.6 times lower with ALA than with PIT.
Discussion
The experimental model and approach used in this study allowed comparison of the tissue accumulation and therapeutic selectivities of agents with different photophysical and photobiological properties. For this purpose three tests (fluorescence detection, therapeutic and histopathological) have been performed. LIF measurements were performed to determine an optimal time between injection and photoirradiation and revealed different kinetics of tissue accumulation for the agents tested (Figure 2 ). In the model used the LIF signals collected from the foot with the tumour were composite signals from the skin and underlying tumour, whereas in the normal foot the signal was obtained from the skin and underlying muscles. Although the fluorescence signal from the tumour was attenuated by the skin, the kinetic patterns observed reflected real concentratic The kinetic pattern of ALA-induc characterised by rapid accumulatic accumulation in normal tissues (Fi maximal tumour-normal tissue rati tion was registered 1 h after injectic rapid decrease in selectivity. In con the tumour, and selectivity of compared with normal tissue rea 48-72 h (Figure 2c ). After injectiol tion and removal in the tumour and observed; however, the fluorescenc the tumour was significantly higher during the first 24 h (Figure 2b ). The selectivity of porphyrin accumulation in the tumour at the time of photoirradiation obtained by the LIF measurements was in the order ALA> Chl> PII (Table I) .
Results of the PDT study using photoirradiation by HIPLS revealed that both the anti-tumour effect and the normal tissue damage index were enhanced with increasing light doses for all agents (Figures 6 and 8) . In order to correctly compare PDT selectivity, an assessment of the normal tissue damage index per equal anti-tumour effect (TGIR) was performed. This evaluation is based on the regression analysis of normal and tumour tissue responses to PDT as a function of the applied light dose. Such an assessment can be performed at the optimal regimen for each PDT agent and disregards the differences in administered doses (tissue concentrations) and differences in their photophysical properties.
The results of the present study showed that with the treatment regimens used Chl was more effective than PII and ALA-induced PpIX for inhibition of tumour growth (Figure 6) , and caused minimal damage (expression of oedema value) 5 6 7 to normal tissue (Table I) tissue damage effects, etc).
,atment (days) The difference in PDT selectivity observed between Chl and PIT correlates well with the LIF test, which showed a mpression after PDT with higher tumour -normal tissue accumulation ratio at the nrg kg '-) was injected 3 h moment of treatment for Chl than for PII. It has been ng kg-l) was injected 24 h shown that the mechanism of anti-tumour effect after PDT Ls in each group were used. with chlorins (Chl or NPe6) and PII is similar and based on *, 240 J cm 2; A, 180 J damage to the microvasculature and blood circulation disturbances leading to tumour necrosis (Kostenich et al., 1991; Nelson et al., 1988) . Nevertheless, different ultrastructural changes in the subendothelial zone, and fragmenta-:n changes in the tissues. tion (NPe6) vs coalescence (PII) of collagen fibres has been ,ed PpIX production was found (Nelson et al., 1988) . It has also been shown that rn in tumour and slower damage to the endothelial cells (with a subsequent release of gure 2a). As a result, the the vasoactive compounds provoking vessel constriction) and io of porphyrin accumulamacromolecular leakage from venules were observed after Dn of ALA, followed by a PDT with PII (Fingar et al., 1990 (Fingar et al., , 1992 PDT (Kostenich et al., 1991; McMahon et al., 1994) . Histological examination carried out in the present study revealed that blood stasis, oedema and haemorrhages occurred in normal and tumour tissues after PDT with both agents. However, certain differences have been found: PH-PDT, as compared with Chl-PDT, caused more pronounced damage to epidermis, induced more severe oedema and subepidermal blister formation, caused damage to the blood vessel walls and induced thrombi formation (Figures 3 and 4) .
ALA-PDT has a different systemic mechanism than either Chl or PH. The endogenous route of ALA-induced PpIX production presupposes that mitochondrial damage leads to direct cell killing (Malik and Lugaci, 1987) . The LIF test data showed the highest tumour-normal accumulation ratio for ALA-induced PpIX in our tumour model. Enhanced PDT selectivity was expected after ALA administration, but in fact was not found at low light doses. The results demonstrated that oedema of the normal foot after ALA-PDT with light doses of 120-180 J cm-2 was more pronounced than after Chl-PDT or PH-PDT, but when the light doses increased, normal tissue damage was less than for PII-PDT ( Figure 8 , Table I ). At the high light doses the selectivity was higher for ALA-PDT than for PII-PDT.
We suggest that these results can be explained by the histological examinations, which showed that the epidermis was extensively damaged after ALA-PDT, as compared with Chl and PH (Figures 3 and 4) . This is consistent with previous findings revealing increased PpIX fluorescence in the epidermis and high skin photosensitivity after ALA administration (Peng et al., 1992; Divaris et al, 1990) . During photoirradiation the relatively thin epidermis layer receives the highest light dose in addition to the preferential production of PpIX occurring in this layer. Therefore, even at low light doses epidermal necrosis and subsequent acute inflammatory reaction can result in pronounced oedema.
In the tumour, some of the morphological changes after ALA-PDT were quite different from those observed after PDT with Chl or PH and could be attributed to direct parenchymal tumour cell kill with slight damage to tumour vasculature. Moderate oedema with significant granulocyte infiltration observed after treatment is the indirect proof of preserved blood circulation in the tissue. Nevertheless, vascular damage during ALA-PDT cannot be excluded at certain light doses, because systemic administration of ALA can induce enhanced PpIX synthesis in the endothelial cells. This fact is based on the observation of blood stasis after photoirradiation with doses of 240 and 300 J cm-'.
In conclusion, it is suggested that selectivity of PDT for different photosensitisers may be determined by biological mechanisms of action such as agent-specific interstitial distribution (binding sites) and the characteristics of tissue damage effects. The results of the present study indicate that integrated information obtained from a LIF study, a PDT selectivity test and a histopathology examination is useful in the evaluation of different agents. The experimental model and approach described can be used to assess new potential photosensitisers.
